{"id":"https://openalex.org/W4393489529","doi":"https://doi.org/10.1111/dom.15579","title":"Dual glucagon\u2010like peptide \u20101 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity","display_name":"Dual glucagon\u2010like peptide \u20101 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity","alternate_titles":[],"publication_year":2024,"publication_date":"2024-04-01","ids":{"openalex":"https://openalex.org/W4393489529","doi":"https://doi.org/10.1111/dom.15579","pmid":"https://pubmed.ncbi.nlm.nih.gov/38562018"},"language":"en","primary_location":{"id":"doi:10.1111/dom.15579","doi":"https://doi.org/10.1111/dom.15579","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.15579","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15579","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4393489529"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15579","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045513511","display_name":"Rajna Golubi\u0107","orcid":"https://orcid.org/0000-0003-0419-9582","observed_orcids":["https://orcid.org/0000-0003-0419-9582"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210116691","display_name":"Wellcome/MRC Institute of Metabolic Science","ror":"https://ror.org/0264dxb48","country_code":"GB","type":"facility","lineage":["https://openalex.org/I241749","https://openalex.org/I2802466933","https://openalex.org/I4210087105","https://openalex.org/I4210116691","https://openalex.org/I87048295","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I4210129944","display_name":"Oxford Centre for Diabetes, Endocrinology and Metabolism","ror":"https://ror.org/03myafa32","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210129944","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Rajna Golubic","raw_affiliation_strings":["Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK","Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0003-0419-9582","affiliations":[{"raw_affiliation_string":"Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210129944"]},{"raw_affiliation_string":"Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210116691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045740290","display_name":"Jane Kennet","orcid":"https://orcid.org/0000-0001-8615-0576","observed_orcids":["https://orcid.org/0000-0001-8615-0576"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210116691","display_name":"Wellcome/MRC Institute of Metabolic Science","ror":"https://ror.org/0264dxb48","country_code":"GB","type":"facility","lineage":["https://openalex.org/I241749","https://openalex.org/I2802466933","https://openalex.org/I4210087105","https://openalex.org/I4210116691","https://openalex.org/I87048295","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jane Kennet","raw_affiliation_strings":["Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210116691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049419220","display_name":"Victoria Parker","orcid":"https://orcid.org/0000-0003-2706-2669","observed_orcids":["https://orcid.org/0000-0003-2706-2669","https://orcid.org/0000-0002-9022-2138"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Victoria Parker","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Cambridge UK"],"raw_orcid":"https://orcid.org/0000-0003-2706-2669","affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Cambridge UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059689508","display_name":"Darren C. Robertson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Darren Robertson","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Cambridge UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Cambridge UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058713189","display_name":"Dan Luo","orcid":"https://orcid.org/0000-0002-8202-7420","observed_orcids":["https://orcid.org/0000-0002-8202-7420"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Luo","raw_affiliation_strings":["Statistics, Biometrics Oncology, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics, Biometrics Oncology, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104067356","display_name":"Lars Bolvig Hansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lars Hansen","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048496451","display_name":"Lutz Jermutus","orcid":"https://orcid.org/0000-0001-7660-8467","observed_orcids":["https://orcid.org/0000-0001-7660-8467"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lutz Jermutus","raw_affiliation_strings":["Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Cambridge UK"],"raw_orcid":"https://orcid.org/0000-0001-7660-8467","affiliations":[{"raw_affiliation_string":"Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Cambridge UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034677869","display_name":"Phil Ambery","orcid":"https://orcid.org/0000-0003-2978-1886","observed_orcids":["https://orcid.org/0000-0003-2978-1886"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Phil Ambery","raw_affiliation_strings":["Late Clinical Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden"],"raw_orcid":"https://orcid.org/0000-0003-2978-1886","affiliations":[{"raw_affiliation_string":"Late Clinical Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032141958","display_name":"Maria Ryaboshapkina","orcid":"https://orcid.org/0000-0003-1385-8869","observed_orcids":["https://orcid.org/0000-0003-1385-8869"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Maria Ryaboshapkina","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden"],"raw_orcid":"https://orcid.org/0000-0003-1385-8869","affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024753140","display_name":"Manasa Surakala","orcid":"https://orcid.org/0000-0002-6158-3460","observed_orcids":["https://orcid.org/0000-0002-6158-3460"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Manasa Surakala","raw_affiliation_strings":["R&D IT, AstraZeneca Cambridge UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D IT, AstraZeneca Cambridge UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004116492","display_name":"Rhianna Che Laker","orcid":"https://orcid.org/0000-0002-0507-7838","observed_orcids":["https://orcid.org/0000-0002-0507-7838"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rhianna C. Laker","raw_affiliation_strings":["Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061067229","display_name":"Michelle Venables","orcid":"https://orcid.org/0000-0002-9380-0060","observed_orcids":["https://orcid.org/0000-0002-9380-0060"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210158597","display_name":"MRC Epidemiology Unit","ror":"https://ror.org/052578691","country_code":"GB","type":"facility","lineage":["https://openalex.org/I241749","https://openalex.org/I4210087105","https://openalex.org/I4210158597","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michelle Venables","raw_affiliation_strings":["MRC Epidemiology Unit, University of Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Epidemiology Unit, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210158597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012520344","display_name":"Albert Koulman","orcid":"https://orcid.org/0000-0001-9998-051X","observed_orcids":["https://orcid.org/0000-0001-9998-051X"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210158597","display_name":"MRC Epidemiology Unit","ror":"https://ror.org/052578691","country_code":"GB","type":"facility","lineage":["https://openalex.org/I241749","https://openalex.org/I4210087105","https://openalex.org/I4210158597","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Albert Koulman","raw_affiliation_strings":["MRC Epidemiology Unit, University of Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Epidemiology Unit, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210158597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055302745","display_name":"Adrian J. Park","orcid":"https://orcid.org/0000-0003-2713-7595","observed_orcids":["https://orcid.org/0000-0003-2713-7595"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210116691","display_name":"Wellcome/MRC Institute of Metabolic Science","ror":"https://ror.org/0264dxb48","country_code":"GB","type":"facility","lineage":["https://openalex.org/I241749","https://openalex.org/I2802466933","https://openalex.org/I4210087105","https://openalex.org/I4210116691","https://openalex.org/I87048295","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adrian Park","raw_affiliation_strings":["Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210116691"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059551923","display_name":"Mark L. Evans","orcid":"https://orcid.org/0000-0001-8122-8987","observed_orcids":["https://orcid.org/0000-0001-8122-8987"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210116691","display_name":"Wellcome/MRC Institute of Metabolic Science","ror":"https://ror.org/0264dxb48","country_code":"GB","type":"facility","lineage":["https://openalex.org/I241749","https://openalex.org/I2802466933","https://openalex.org/I4210087105","https://openalex.org/I4210116691","https://openalex.org/I87048295","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mark Evans","raw_affiliation_strings":["Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0001-8122-8987","affiliations":[{"raw_affiliation_string":"Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210116691"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5045513511","https://openalex.org/A5059551923"],"corresponding_institution_ids":["https://openalex.org/I241749","https://openalex.org/I40120149","https://openalex.org/I4210116691","https://openalex.org/I4210129944"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":4.8696,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.95846784,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"26","issue":"7","first_page":"2634","last_page":"2644"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cotadutide","display_name":"cotadutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8889999985694885},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8830000162124634},{"id":"https://openalex.org/keywords/energy-intake","display_name":"energy intake","score":0.9940000176429749},{"id":"https://openalex.org/keywords/energy-expenditure","display_name":"energy expenditure","score":0.9729999899864197},{"id":"https://openalex.org/keywords/energy-balance","display_name":"energy balance","score":0.8399999737739563},{"id":"https://openalex.org/keywords/appetite-regulation","display_name":"appetite regulation","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8602625131607056},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8328168988227844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6811802387237549},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.6503251791000366},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5859186053276062},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5504419207572937},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5006310939788818},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.47770097851753235},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.4442306458950043},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4285683035850525},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.4240856468677521},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.35963183641433716},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2784543037414551},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16687974333763123},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002149","descriptor_name":"Energy Intake","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004734","descriptor_name":"Energy Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1111/dom.15579","doi":"https://doi.org/10.1111/dom.15579","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.15579","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15579","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:38562018","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38562018","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/366303","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/366303","pdf_url":"https://www.repository.cam.ac.uk/bitstreams/e4e852ee-8ee8-48cf-8696-448004e1c120/download","source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/366539","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/366539","pdf_url":"https://www.repository.cam.ac.uk/bitstreams/17a74a66-1262-4640-b919-7bd839bd1bcd/download","source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"doi:10.17863/cam.107281","doi":"https://doi.org/10.17863/cam.107281","is_oa":true,"landing_page_url":"https://doi.org/10.17863/cam.107281","pdf_url":null,"source":{"id":"https://openalex.org/S7407050737","display_name":"Apollo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1111/dom.15579","doi":"https://doi.org/10.1111/dom.15579","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.15579","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15579","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G139696651","display_name":null,"funder_award_id":"(BRC-1215-20014)","funder_id":"https://openalex.org/F4320336709","funder_display_name":"NIHR Cambridge Biomedical Research Centre"},{"id":"https://openalex.org/G299057155","display_name":null,"funder_award_id":"[IS-BRC-1215-20014","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G370598735","display_name":null,"funder_award_id":"BRC1215-20014","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G469522804","display_name":null,"funder_award_id":"IS-BRC-1215-20014","funder_id":"https://openalex.org/F4320336709","funder_display_name":"NIHR Cambridge Biomedical Research Centre"},{"id":"https://openalex.org/G8585681489","display_name":null,"funder_award_id":"146281","funder_id":"https://openalex.org/F4320321578","funder_display_name":"Cambridge University Hospitals"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320321578","display_name":"Cambridge University Hospitals","ror":"https://ror.org/04v54gj93"},{"id":"https://openalex.org/F4320336709","display_name":"NIHR Cambridge Biomedical Research Centre","ror":"https://ror.org/05m8dr349"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4393489529.pdf","grobid_xml":"https://content.openalex.org/works/W4393489529.grobid-xml"},"referenced_works_count":71,"referenced_works":["https://openalex.org/W5184979","https://openalex.org/W138867107","https://openalex.org/W1547965481","https://openalex.org/W1580839177","https://openalex.org/W1773084519","https://openalex.org/W1970638023","https://openalex.org/W1993582432","https://openalex.org/W1998200369","https://openalex.org/W2003198450","https://openalex.org/W2015178974","https://openalex.org/W2025210455","https://openalex.org/W2028637607","https://openalex.org/W2038654688","https://openalex.org/W2039772960","https://openalex.org/W2059743234","https://openalex.org/W2062367689","https://openalex.org/W2085655607","https://openalex.org/W2103274121","https://openalex.org/W2115939390","https://openalex.org/W2118019244","https://openalex.org/W2128939426","https://openalex.org/W2135978651","https://openalex.org/W2148623180","https://openalex.org/W2150622862","https://openalex.org/W2154497567","https://openalex.org/W2164771187","https://openalex.org/W2169456326","https://openalex.org/W2179438025","https://openalex.org/W2237976954","https://openalex.org/W2301441485","https://openalex.org/W2316534927","https://openalex.org/W2317888997","https://openalex.org/W2319606026","https://openalex.org/W2425644022","https://openalex.org/W2432815617","https://openalex.org/W2464238397","https://openalex.org/W2528810881","https://openalex.org/W2563047690","https://openalex.org/W2564427213","https://openalex.org/W2591832038","https://openalex.org/W2592811885","https://openalex.org/W2593691145","https://openalex.org/W2751884637","https://openalex.org/W2790926033","https://openalex.org/W2794396820","https://openalex.org/W2802400646","https://openalex.org/W2803540340","https://openalex.org/W2806881873","https://openalex.org/W2808958607","https://openalex.org/W2808959426","https://openalex.org/W2813443256","https://openalex.org/W2904592340","https://openalex.org/W2912441125","https://openalex.org/W2967529944","https://openalex.org/W2981305821","https://openalex.org/W2982363774","https://openalex.org/W3002699912","https://openalex.org/W3027852565","https://openalex.org/W3041548136","https://openalex.org/W3160773731","https://openalex.org/W3165203237","https://openalex.org/W3196916730","https://openalex.org/W4200161106","https://openalex.org/W4205614799","https://openalex.org/W4281934192","https://openalex.org/W4292793563","https://openalex.org/W4292822806","https://openalex.org/W4295094341","https://openalex.org/W4317930838","https://openalex.org/W4381681857","https://openalex.org/W4386570539"],"related_works":["https://openalex.org/W3176479934","https://openalex.org/W3159068931","https://openalex.org/W1547965481","https://openalex.org/W2981305821","https://openalex.org/W4396852549","https://openalex.org/W2148623180","https://openalex.org/W2046778213","https://openalex.org/W4225098447","https://openalex.org/W2790926033","https://openalex.org/W2523976390"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"establish":[2],"which":[3],"components":[4],"of":[5,17,94],"energy":[6,84,88],"balance":[7],"mediate":[8],"the":[9,99,106,110,129],"clinically":[10],"significant":[11],"weight":[12,77,118],"loss":[13,192],"demonstrated":[14],"with":[15,46,65,141,193,201],"use":[16],"cotadutide,":[18],"a":[19,34,51],"glucagon-like":[20],"peptide-1":[21],"(GLP-1)/glucagon":[22],"receptor":[23],"dual":[24],"agonist,":[25],"in":[26,41,83,98,105,152,206],"early-phase":[27],"studies.":[28],"MATERIALS":[29],"AND":[30],"METHODS:":[31],"We":[32],"conducted":[33],"phase":[35],"2a,":[36],"single-centre,":[37],"randomized,":[38],"placebo-controlled":[39],"trial":[40],"overweight":[42],"and":[43,87,102,124,131,177],"obese":[44],"adults":[45],"type":[47],"2":[48],"diabetes.":[49],"Following":[50],"16-day":[52],"single-blind":[53],"placebo":[54,107,132,144,162],"run-in,":[55],"participants":[56,96],"were":[57],"randomized":[58],"2:1":[59],"to":[60],"double-blind":[61],"42-day":[62],"subcutaneous":[63],"treatment":[64],"cotadutide":[66,100,130,142,160,194],"(100-300":[67],"\u03bcg":[68],"daily)":[69],"or":[70],"placebo.":[71],"The":[72,112],"primary":[73],"outcome":[74],"was":[75,120,139,163],"percentage":[76],"change.":[78],"Secondary":[79],"outcomes":[80],"included":[81],"change":[82,119],"intake":[85],"(EI)":[86],"expenditure":[89],"(EE).":[90],"RESULTS:":[91],"A":[92],"total":[93],"12":[95],"(63%)":[97],"group":[101,108],"seven":[103],"(78%)":[104],"completed":[109],"study.":[111],"mean":[113],"(90%":[114,165,179],"confidence":[115],"interval":[116],"[CI])":[117],"-4.0%":[121],"(-4.9%,":[122],"-3.1%)":[123],"-1.4%":[125],"(-2.7%,":[126],"-0.1%)":[127],"for":[128,159],"groups,":[133],"respectively":[134],"(p":[135],"=":[136,149,170],"0.011).":[137,150],"EI":[138],"lower":[140],"versus":[143,161],"(-41.3%":[145],"[-66.7,":[146],"-15.9];":[147],"p":[148,169,183],"Difference":[151],"EE":[153],"(per":[154],"kJ/kg":[155],"lean":[156],"body":[157],"mass)":[158],"1.0%":[164],"CI":[166,180],"-8.4,":[167],"10.4;":[168],"0.784),":[171],"assessed":[172,186],"by":[173,187,198],"doubly":[174],"labelled":[175],"water,":[176],"-6.5%":[178],"-9.3,":[181],"-3.7;":[182],"<":[184],"0.001),":[185],"indirect":[188],"calorimetry.":[189],"CONCLUSION:":[190],"Weight":[191],"is":[195],"primarily":[196],"driven":[197],"reduced":[199],"EI,":[200],"relatively":[202],"small":[203],"compensatory":[204],"changes":[205],"EE.":[207]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4393489529","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2024-04-03T00:00:00"}
